Tag: Biotechnology

Modalis
United States

Modalis Announces Partnership with Ginkgo Bioworks

Modalis Joins Ginkgo’s Technology Network TOKYO & WALTHAM, Mass.–(BUSINESS WIRE)–Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announced that it has entered into an agreement with Ginkgo Bioworks (Ginkgo) to join the Ginkgo Technology Network. This strategic alliance will enable Ginkgo’s global customers in the cell and gene therapy fields to access Modalis’ proprietary epigenome modulation technology, CRISPR-GNDM® (Guide Nucleotide-Directed Modulation). Modalis’ CRISPR-GNDM® Technology is capable of activating … Continue reading Modalis Announces Partnership with Ginkgo Bioworks

Impact Newswire
BioCT
United States

BioCT Welcomes Mike Stow of Medtronic to Its Board of Directors

NEW HAVEN, Conn.–(BUSINESS WIRE)–BioCT, Connecticut’s life sciences trade association, is thrilled to announce the appointment of Mike Stow, Vice President of Global Marketing for Robotic Surgical Technologies in the Surgical business of Medtronic, a global leader in healthcare technology, to its Board of Directors. With over 15 years of experience in the medical technologies sector, Mike brings a wealth of knowledge and leadership to the … Continue reading BioCT Welcomes Mike Stow of Medtronic to Its Board of Directors

Impact Newswire
Xencor
United States

Xencor Appoints Bart Cornelissen as Chief Financial Officer

PASADENA, Calif. – Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen to senior vice president and chief financial officer. Mr. Cornelissen has more than 20 years of experience in corporate financial planning, analysis and transaction support. Before joining Xencor, he was most recently vice president, corporate finance … Continue reading Xencor Appoints Bart Cornelissen as Chief Financial Officer

Impact Newswire
Rachael Brake
United States

Rachael Brake, PhD, Joins Zephyr AI as Chief Scientific Officer

MCLEAN, Va.–(BUSINESS WIRE)–Zephyr AI, Inc. (“Zephyr AI”), a healthcare technology company committed to developing fast and explainable artificial intelligence (AI) solutions to democratize precision medicine, today announced the appointment of Rachael Brake, PhD, as its new Chief Scientific Officer. “Having spent decades working in big pharma and biotech spanning roles in research, development and commercial, Rachael comes to Zephyr with a unique breadth of experience”Post this … Continue reading Rachael Brake, PhD, Joins Zephyr AI as Chief Scientific Officer

Impact Newswire
Terragia
United States

Terragia Secures $6M to Develop Cost-Competitive, Low-Carbon Biofuel Technology

The startup expanded its leadership team with climate tech veteran Kristin Brief joining as CEO, Lee Lynd transitions to CTO. HANOVER, N.H.–(BUSINESS WIRE)–Terragia Biofuel, a technology startup aiming to drive the next generation of biofuels, today announced it has raised a $6 million seed round led by Engine Ventures and Energy Impact Partners (EIP). The company will use the capital to commercialize its novel biology-based approach to converting cellulosic … Continue reading Terragia Secures $6M to Develop Cost-Competitive, Low-Carbon Biofuel Technology

Impact Newswire
BioConsortia
United States

BioConsortia secures $15 million in latest funding round

Funding global pipeline development of transformational nitrogen-fixing and nematicidal seed treatment products, and extending BioConsortia’s gene-editing leadership position April 01, 2024 10:12 AM Eastern Daylight Time DAVIS, Calif.–(BUSINESS WIRE)–BioConsortia, Inc., a leading agricultural technology company that discovers, designs and licenses advanced microbial products to reduce the ecological impacts of agriculture while ensuring crop productivity, today announced that the Company has closed an internal financing round … Continue reading BioConsortia secures $15 million in latest funding round

Impact Newswire
Gilead Sciences
United States

Gilead Sciences Announces Completion of Acquisition of CymaBay

Acquisition Reinforces Gilead’s Leadership in Developing Innovative Therapies For Challenging Liver Diseases March 22, 2024 09:18 AM Eastern Daylight Time FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for approximately $4.3 billion in total equity value. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of … Continue reading Gilead Sciences Announces Completion of Acquisition of CymaBay

Impact Newswire
A2 Bio
United States

A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors

Robinson to Lead Next Phase of Company’s Expansion and Pipeline Advancement March 25, 2024 09:00 AM Eastern Daylight Time AGOURA HILLS, Calif.–(BUSINESS WIRE)–A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to address the high unmet needs in cancer, today announced the appointment of James Robinson as its Chief Executive Officer and a member of its Board of Directors, … Continue reading A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors

Impact Newswire